We are live on ! Find out more
HLTH

Cue Health Inc. Common Stock

Delisted

HLTH was delisted on the 5th of June, 2024.

86 hedge funds and large institutions have $371M invested in Cue Health Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 34 funds opening new positions, 21 increasing their positions, 20 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

209% more first-time investments, than exits

New positions opened: 34 | Existing positions closed: 11

32% more funds holding

Funds holding: 6586 (+21)

17% more funds holding in top 10

Funds holding in top 10: 67 (+1)

5% more repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 20

7% less call options, than puts

Call options by funds: $5.05M | Put options by funds: $5.46M

29% less capital invested

Capital invested by funds: $521M → $371M (-$150M)

Holders
86
Holders Change
+21
Holders Change %
+32.31%
% of All Funds
1.36%
Holding in Top 10
7
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+16.67%
% of All Funds
0.11%
New
34
Increased
21
Reduced
20
Closed
11
Calls
$5.05M
Puts
$5.46M
Net Calls
-$401K
Net Calls Change
-$2.25M
Name Holding Trade Value Shares
Change
Change in
Stake
Northern Trust
26
Northern Trust
Illinois
$627K -$34K -3,759 -4%
Capstone Investment Advisors
27
Capstone Investment Advisors
New York
$596K +$836K +92,372 New
Jane Street
28
Jane Street
New York
$521K +$730K +80,758 New
SO
29
STRS Ohio
Ohio
$516K +$693K +76,600 +2,253%
Bank of America
30
Bank of America
North Carolina
$507K +$612K +67,682 +616%
MCM
31
Manchester Capital Management
Vermont
$464K +$650K +71,865 New
E
32
Ergoteles
New York
$363K +$509K +56,300 New
AF
33
Allworth Financial
California
$355K +$181K +20,000 +57%
D.E. Shaw & Co
34
D.E. Shaw & Co
New York
$323K +$257K +28,370 +131%
EMG
35
ETF Managers Group
New Jersey
$289K -$452 -50 -0.1%
First Manhattan
36
First Manhattan
New York
$271K +$155K +17,140 +69%
FWM
37
FFT Wealth Management
Pennsylvania
$264K +$371K +40,962 New
N
38
Nuveen
North Carolina
$212K +$96.7K +10,689 +48%
Bank of New York Mellon
39
Bank of New York Mellon
New York
$211K +$26.5K +2,928 +10%
PPA
40
Parametric Portfolio Associates
Washington
$211K +$297K +32,783 New
Charles Schwab
41
Charles Schwab
California
$205K +$697 +77 +0.2%
CSS
42
Cubist Systematic Strategies
Connecticut
$205K +$287K +31,783 New
ECM
43
ExodusPoint Capital Management
New York
$185K +$152K +16,759 +140%
Morgan Stanley
44
Morgan Stanley
New York
$174K +$57.3K +6,338 +31%
AI
45
Alphabet Inc
California
$174K +$244K +27,000 New
PHK
46
Point72 Hong Kong
Hong Kong
$145K +$203K +22,492 New
VFPW
47
Vantage Financial Partners (Wisconsin)
Wisconsin
$129K +$181K +20,000 New
RhumbLine Advisers
48
RhumbLine Advisers
Massachusetts
$96K +$43.4K +4,795 +48%
MCM
49
Morton Capital Management
California
$93.3K
Victory Capital Management
50
Victory Capital Management
Texas
$89K +$120K +13,250 New

HLTH Hedge Fund Activity: Q1 2022 in Review

86 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Cue Health Inc. Common Stock (HLTH) for Q1 2022, worth a combined $371M — down 29% from $521M a quarter earlier.

Buyers outnumbered sellers: 34 funds opened new HLTH positions and 11 closed out — a net gain of 23 holders — while 21 added to existing stakes and 20 trimmed.

The largest buyer was Oakmont Corp, opening a new position worth an estimated $88.6M. The largest seller was Portolan Capital Management, exiting entirely with an estimated $10.6M sold.

  • 86 institutional investors held Cue Health Inc. Common Stock (HLTH) as of Q1 2022, up from 65 in Q4 2021.
  • Funds reported $371M of Cue Health Inc. Common Stock stock for Q1 2022, down 29% quarter-over-quarter.
  • 34 funds opened new Cue Health Inc. Common Stock positions in Q1 2022 and 11 closed out, a net change of +23 holders.
  • The largest Cue Health Inc. Common Stock buyer in Q1 2022 was Oakmont Corp, an estimated $88.6M added.
  • The largest Cue Health Inc. Common Stock seller in Q1 2022 was Portolan Capital Management, an estimated $10.6M sold.

Based on aggregated 13F filings for Q1 2022.